Multiplex immunoassay measurement of amyloid-β42 to amyloid-β40 ratio in plasma discriminates between dementia due to Alzheimer’s disease and dementia not due to Alzheimer’s disease

Title
Multiplex immunoassay measurement of amyloid-β42 to amyloid-β40 ratio in plasma discriminates between dementia due to Alzheimer’s disease and dementia not due to Alzheimer’s disease
Authors
Keywords
Plasma, Amyloid-β, Alzheimer’s disease, Biomarker, Assay validation, Dementia
Journal
EXPERIMENTAL BRAIN RESEARCH
Volume 236, Issue 5, Pages 1241-1250
Publisher
Springer Nature
Online
2018-02-26
DOI
10.1007/s00221-018-5210-x

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started